Authors:
Tchilian, EZ
Wallace, DL
Dawes, R
Imami, N
Burton, C
Gotch, F
Beverly, PCL
Citation: Ez. Tchilian et al., A point mutation in CD45 may be associated with an increased risk of HIV-1infection (vol 15, pg 1892, 2001), AIDS, 15(16), 2001, pp. 2210-2210
Authors:
Imami, N
Hardy, G
Burton, C
Pires, A
Pido-Lopez, J
Moss, R
Gazzard, B
Gotch, F
Citation: N. Imami et al., Immune responses and reconstitution in HIV-1 infected individuals: impact of anti-retroviral therapy, cytokines and therapeutic vaccination, IMMUNOL LET, 79(1-2), 2001, pp. 63-76
Authors:
Tchilian, EZ
Wallace, DL
Imami, N
Liao, HX
Burton, C
Gotch, F
Martinson, J
Haynes, BF
Beverley, PCL
Citation: Ez. Tchilian et al., The exon A (C77G) mutation is a common cause of abnormal CD45 splicing in humans, J IMMUNOL, 166(10), 2001, pp. 6144-6148
Citation: J. Pido-lopez et al., Both age and gender affect thymic output: more recent thymic migrants in females than males as they age, CLIN EXP IM, 125(3), 2001, pp. 409-413
Authors:
Wilson, JDK
Imami, N
Watkins, A
Gill, J
Hay, P
Gazzard, B
Westby, M
Gotch, FM
Citation: Jdk. Wilson et al., Loss of CD4(+) T cell proliferative ability but not loss of human immunodeficiency virus type 1 specificity equates with progression to disease, J INFEC DIS, 182(3), 2000, pp. 792-798
Authors:
Imami, N
Antonopoulos, C
Hardy, GAD
Gazzard, B
Gotch, FM
Citation: N. Imami et al., Assessment of type 1 and type 2 cytokines in HIV type 1-infected individuals: Impact of highly active antiretroviral therapy, AIDS RES H, 15(17), 1999, pp. 1499-1508
Authors:
Imami, N
Hardy, GAD
Nelson, MR
Morris-Jones, S
Al-Shahi, R
Antonopoulos, C
Gazzard, B
Gotch, FM
Citation: N. Imami et al., Induction of HTV-1-specific T cell responses by administration of cytokines in late-stage patients receiving highly active anti-retroviral therapy, CLIN EXP IM, 118(1), 1999, pp. 78-86
Authors:
McKay, PF
Imami, N
Johns, M
Taylor-Fishwick, DA
Sedibane, LM
Totty, NF
Hsuan, JJ
Palmer, DB
George, AJT
Foxwell, BMJ
Ritter, MA
Citation: Pf. Mckay et al., The gp200-MR6 molecule which is functionally associated with the IL-4 receptor modulates B cell phenotype and is a novel member of the human macrophage mannose receptor family, EUR J IMMUN, 28(12), 1998, pp. 4071-4083